Trial intelligence / Profile preview

Folic acid and vitamin B12 supplementation with metformin in women with polycystic ovary syndrome

IRCT201108171760N14Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
Aug 2011
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of metformin, folic acid and cyanocobalamin in polycystic ovary syndrome (PCOS), sponsored by Babol University of Medical Sciences. Primary endpoint: Change in plasma homocysteine levels. Started Aug 2011; status: completed.

02

Drugs

metforminfolic acidcyanocobalamin
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on IRCT201108171760N14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201108171760N14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call